AstraZeneca contributes to global rescue effort for Haiti

Wednesday, 13 January 2010

AstraZeneca is contributing to the global rescue effort in the wake of Haiti’s devastating earthquake. We have donated antibiotic and respiratory medicines (Meronem, Pulmicort and Rhinocort) through US charity AmeriCares and through Health Partners International in Canada, cardiovascular, gastrointestinal and respiratory (Tenormin, Losec, Nexium, Bricanyl, Pulmicort Turbuhaler) medicines.

In addition to our initial donation of $160,000, we have now donated a further $340,000 to the British Red Cross Emergency Appeal. We have also committed an additional $500,000 to support a longer-term disaster recovery programme that will give the people of Haiti the help they need to re-build their lives and their communities. We are currently working with AstraZeneca colleagues in the region to identify appropriate projects and partners.

Hear directly from our scientists on LabTalk, discussing how we're applying innovation to our scientific discovery.

BIO 2013: A round-up 14 May 2013

BIO 2013: A round-up

Focus_Oncology_LabTHM 30 April 2013

A selective technology to beat cancer cells